The Conundrum of Recurrent Low Grade Tumors - James McKiernan
Dr. James McKiernan discussion the issues and dilemmas in low grade bladder cancer and the challenges that are being faced with treating recurrent low-grade bladder tumors. He focuses his presentation on lower risk tumors that recur posing major burden on patients and the health care system. Patients that fall into the low stage and low grade Ta category of papillary low grade bladder cancer. A narrow subset of the overall staging of bladder cancer.
Additional Content on Low Grade Bladder Cancer
Mixed low- and high-grade non-muscle-invasive bladder cancer: A histological subtype with favorable outcome, "Beyond the Abstract," by Matthew Danzig, BS; Tina Schubert, MD; and James McKiernan, MD
EAU 2017: Debate - Do we need to follow-up in low grade bladder tumor after 12 months?-Yes (EAU Guidelines)
AUA 2017: Immediate intravesical chemotherapy for low grade bladder tumors in California: an underutilized practice and its impact on recurrence
James McKiernan, MD John K. Lattimer Professor and Chairman, Department of Urology, Columbia University and New York Presbyterian Hospital